Cargos activos de Andrew Muratore
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Director/Miembro de la Junta | 17/11/2021 | - |
| Corporate Officer/Principal | 17/11/2021 | - |
Historial de carrera de Andrew Muratore
Estadísticas
Internacional
| Canadá | 2 |
Operativa
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Muratore
- Experiencia